Skin of Color
The ability to differentiate MF from mimickers permits early diagnosis and treatment, potentially improving long-term outcomes.
Lawrence A. Mark, MD, PhD
One expert sheds light on the current state of infectious diseases in dermatology and shares insights on new data and therapies.
Ted Pigeon, Senior Associate Editor
EHRs are purported to have various tangible and intangible benefits for physicians, but those benefits may not be readily apparent.
Jeffrey M. Suchniak, MD
Experienced physicians describe dispensing strategies that provide the greatest benefit to the patient and the practice.
Paul Winnington, Editorial Director
Specialists describe how a disrupted barrier contributes to common dermatoses and offer strategies for treatment.
Joseph Bikowski, MD and Matthew Zirwas, MD
Each year the Office of Inspector General publishes a workplan for the year ahead. What does 2010 hold?
Sharon Andrews, RN, CCS-P
An interview with a Social Media Marketing Expert offers insights for practices.
Dana Jacoby, M.B.A., M.H.S.
Ongoing developments in the field of gene expression may finally be leading to clinical tools.
Section Editor: Jonathan Wolfe, MD
Early head-to-head trials have proven valuable in the evaluation of newer and established biologic therapies. What will the future hold?
Jerry Bagel, MD
To minimize malpractice risk and enhance the patient experience, think of informed consent as a process of education and conversation.
As the MRSA epidemic spreads, the search for novel therapies intensifies. NO nanoparticles show promise as an option worth exploring.
Adam Friedman, MD
As insurance coverage shifts, deductibles are climbing. Practices must be vigilant about collecting payments and willing to accommodate patients' “financial schedules.”
Joel Schlessinger, MD
As we near the season of “Awareness” months, this is the time to plan practice programs and educational activities. Here's your calendar update.
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
March 2010 Clinical Insights